Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors

NEXT STORY
NeurMedix Obtains FDA Authorization for Pivotal Phase 3 Alzheimer’s Trial
PREV STORY
Arch Biopartners Receives Ethics Committee Approval in Turkey to Dose Additional Patients in the Phase II Trial for LSALT Peptide
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Anesthesia Equipment Market Size Will Reach to USD 16 Billion by 2026, with a 6.5% CAGR: Facts & Factors

author_avatar
NASDAQ Market News

Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director

author_avatar
NASDAQ Market News

Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene fusion-positive patients with bile duct cancer (iCCA)

author_avatar
NASDAQ Market News